An Investigational Immuno-therapy Study to Evaluate Safety and Effectiveness in Patients With Melanoma That Has Spread to the Brain, Treated With Nivolumab in Combination With Ipilimumab, Followed by Nivolumab by Itself
Clinical trial NCT02320058 · COMPLETED
Trial details
- NCT number
- NCT02320058
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-05
- Primary completion
- 2020-09-08
- Enrollment
- 119
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.